Radiolabeled mAbs as Molecular Imaging and/or Therapy Agents Targeting PSMA

被引:12
|
作者
Psimadas, Dimitrios [1 ]
Valotassiou, Varvara [1 ]
Alexiou, Sotiria [1 ]
Tsougos, Ioannis [1 ]
Georgoulias, Panagiotis [1 ]
机构
[1] Univ Thessaly, Sch Med, Univ Hosp Larissa, Dept Nucl Med, Larisa, Greece
关键词
Antibodies; radiolabeling; PSMA; prostate cancer; LU-177-PSMA-617 RADIOLIGAND THERAPY; METASTATIC PROSTATE-CANCER; MEMBRANE ANTIGEN PSMA; MONOCLONAL-ANTIBODY J591; IN-VIVO; PRECLINICAL EVALUATION; EXTRACELLULAR DOMAIN; RADIATION-DOSIMETRY; INHIBITORS; TUMORS;
D O I
10.1080/07357907.2018.1430816
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Molecular imaging and therapy is a rapidly evolving field in research and clinical medicine. The use of the exciting and attractive properties of radioisotopes for imaging and therapy has made Nuclear Medicine very significant when it comes to molecular imaging/therapy. Monoclonal Antibodies (mAbs) on the other hand are very important targeting biomolecules with high affinity that can "carry" the radioisotope of choice. Herein we make a brief overview of the radiolabeled mAbs that target prostate specific membrane antigen (PSMA) and their use in the management of patients with prostate cancer (PCa).
引用
收藏
页码:118 / 128
页数:11
相关论文
共 50 条
  • [21] PSMA-Targeting Imaging and Theranostic Agents-Current Status and Future Perspective
    Debnath, Sashi
    Zhou, Ning
    McLaughlin, Mark
    Rice, Samuel
    Pillai, Anil K.
    Hao, Guiyang
    Sun, Xiankai
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
  • [22] Targeting of microbubbles: contrast agents for ultrasound molecular imaging
    Wang, Shiying
    Hossack, John A.
    Klibanov, Alexander L.
    JOURNAL OF DRUG TARGETING, 2018, 26 (5-6) : 420 - 434
  • [23] Branched peptides as targeting agents for tumor imaging and therapy
    Brunetti, J.
    Falciani, C.
    Lelli, B.
    Ravenni, N.
    Pini, A.
    Depau, L.
    Lozzi, L.
    Lapo, B.
    Moretti, R.
    Bracci, L.
    EJC SUPPLEMENTS, 2010, 8 (07): : 33 - 34
  • [24] Investigation of the Molecular Design of PSMA-targeting Radioligands for Imaging of Prostate Cancer
    Lundmark, F.
    Olanders, G.
    Rinne, S. S.
    Abouzayed, A.
    Orlova, A.
    Rosenstrom, U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S18 - S19
  • [25] Targeting of Breast Cancer: Molecular Imaging and Therapy
    Padmanabhan, Parasuraman
    Goggi, Julian
    Bejot, Romain
    Bhakoo, Kishore K.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (04) : 528 - 538
  • [26] Molecular Targeting Agents in Cancer Therapy: Science and Society
    Shaikh, Asim Jamal
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (04) : 1705 - 1708
  • [27] Molecular targeting of the lymphovascular system for imaging and therapy
    Schoder, Heiko
    Glass, Edwin C.
    Pecking, Alain P.
    Harness, Jay K.
    Wallace, Anne M.
    Hirnle, Peter
    Alberini, Jean L.
    Vilain, Didier
    Larson, Steven M.
    Hoh, Carl K.
    Vera, David R.
    CANCER AND METASTASIS REVIEWS, 2006, 25 (02) : 185 - 201
  • [28] Molecular targeting of the lymphovascular system for imaging and therapy
    Heiko Schöder
    Edwin C. Glass
    Alain P. Pecking
    Jay K. Harness
    Anne M. Wallace
    Peter Hirnle
    Jean L. Alberini
    Didier Vilain
    Steven M. Larson
    Carl K. Hoh
    David R. Vera
    Cancer and Metastasis Reviews, 2006, 25 : 185 - 201
  • [29] Targeting NCA-95 and other granulocyte antigens and receptors with radiolabeled monoclonal antibodies (Mabs)
    Meller, J.
    Liersch, T.
    Oezerden, M. M.
    Sahlmann, C. -O.
    Meller, B.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 54 (06): : 582 - 598
  • [30] RADIOLABELED AGENTS FOR SPECT IMAGING OF BRAIN PERFUSION
    WALOVITCH, RC
    WILLIAMS, SJ
    LAFRANCE, ND
    NUCLEAR MEDICINE AND BIOLOGY, 1990, 17 (01): : 77 - 83